California voters will be confronted tomorrow with two ballot initiatives on pharmaceutical pricing: Proposition 78, promoted mainly by the pharmaceutical industry, and Proposition 79, promoted mainly by the public employee unions.
The bottom line: Prop. 78 will increase drug access and reduce drug prices for those in need precisely because it will enable the drug producers to make more money, by discounting drugs for those less fortunate without being forced to offer the same discounts to the federal government. Prop. 79 explicitly would reduce drug access for the needy in an effort to subsidize the middle class, and would engender a tidal wave of litigation.
The bottom line: Prop. 78 will increase drug access and reduce drug prices for those in need precisely because it will enable the drug producers to make more money, by discounting drugs for those less fortunate without being forced to offer the same discounts to the federal government. Prop. 79 explicitly would reduce drug access for the needy in an effort to subsidize the middle class, and would engender a tidal wave of litigation.
Consider a drug that costs, say, 20 cents per pill to produce after the enormous investments in research and development have been made. A wealthy patient might be willing to pay, say, $1 for each pill; but someone less fortunate might be able to afford, say, only 25 cents. Is it profitable for the drug producer to sell the drug to the poorer patient for 21 cents? The answer is yes, as long as the producer does not have to give the same price break to the wealthier patient.
Beginning in 1990, federal law in effect made it illegal to offer that price break to the poorer patient, because then the drug producers would have been required to give that same price to the feds. And so the need to cover large research and development costs prevented the drug producers from using such differential pricing to increase access to medicines for the poor.
The Bush Administration has changed the rules so that the producers now may give such discounts to those less fortunate through Patient Assistance Programs, without being forced to offer those same low prices to federal drug programs. Prop. 78 enables the producers to engage in such discounting in
6 comments:
Dr. Zycher, despite your best efforts to make people aware they are killing the golden goose, our friends on the left do not accept the principle.
They would rather have us all eat gruel than let some get caviar, even though the rest of us would still get pizza (with two toppings!).
Nor are they aware the reason most vaccines are no longer made in the US is because said goose has already been squeezed bigtime.
But I do hope you'll keep trying.
I'm voting "No" on both propositions. 79 is incredibly flawed and based on a program from Maine that died a dismal death and deserves to be cast to the dung heap of stupid ideas lots of people want to vote for. (You know, like a President George W. Bush?)
78 is an entirely voluntary program, and I do not trust the generosity of the pharmaceutical industry.
Realizing that in the above I sound like a complete reactionary vis-a-vis Proposition 78, please let me elaborate that my main objection stems from the onerous and punitive means tests that it imposes.
I am more afraid of direct democracy than a fan of it also, Connie. If that makes me sound like a complete reactionary, then so be it.
Tom, we agree there. The proposition system in California is flawed to begin with, but when you couple it with voter malaise and society's general inertia towards entertainment over information, it's a real problem.
Yah, JE. I believe California's initiative process grew out of the progressive movement's frustration with the entrenched powers that be, sometime in the early 20th century.
I agree in principle with the people having a nuclear option, but the button shouldn't be pressed a half-dozen times a year, every year, as it is now.
Post a Comment